Skip to main content
Fig. 2 | Breast Cancer Research

Fig. 2

From: An immune stratification reveals a subset of PD-1/LAG-3 double-positive triple-negative breast cancers

Fig. 2

Univariate Cox regression analysis of tumor-infiltrating lymphocytes (TILs), immune markers and checkpoint receptors for relapse-free survival and overall survival in triple-negative breast cancer. Forest plot of hazard ratios (HR) with 95% confidence intervals (CI) for relapse-free survival (a) and overall survival (b), for lymphocyte-predominant breast cancer (LPBC) (cutoff value ≥50%), TIL scores (treated as a continuous variable for each 10% increment), immune markers (CD4, CD8, and forkhead box protein 3 (FOXP3); median values were used as the cutoff), and immune checkpoints (programmed cell death 1 (PD-1), and lymphocyte activation gene 3 (LAG-3); a cutoff value ≥5% was used)

Back to article page